Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01510119
Title Autophagy Inhibition to Augment mTOR Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine in Patients With Previously Treated Renal Cell Carcinoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Abramson Cancer Center of the University of Pennsylvania
Indications

renal cell carcinoma

Therapies

Everolimus + Hydroxychloroquine

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Medicine and Dentistry of New Jersey New Brunswick New Jersey United States Details
Abramson Cancer Center of the University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
University of Pittsburgh, Hillman Cancer Center Pittsburgh Pennsylvania United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field